http://orcid.org/0000-0001-7853-0042
Citations (105)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jing Huang, Zhijian Lin, Yu Wang, Xueli Ding & Bing Zhang. (2023) Wuling San Based on Network Pharmacology and in vivo Evidence Against Hyperuricemia via Improving Oxidative Stress and Inhibiting Inflammation. Drug Design, Development and Therapy 17, pages 675-690.
Read now
Read now
Armachius James, Hengming Ke, Ting Yao & Yousheng Wang. (2023) The Role of Probiotics in Purine Metabolism, Hyperuricemia and Gout: Mechanisms and Interventions. Food Reviews International 39:1, pages 261-277.
Read now
Read now
Rui Zhao, Zimai Li, Yuqing Sun, Wei Ge, Mingyu Wang, Huaiwei Liu, Luying Xun & Yongzhen Xia. (2022) Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment. Gut Microbes 14:1.
Read now
Read now
Jun Li, Jinwei Li & Liuping Fan. (2022) Recent Advances in Alleviating Hyperuricemia Through Dietary Sources: Bioactive Ingredients and Structure–activity Relationships. Food Reviews International 0:0, pages 1-35.
Read now
Read now
Pannipa Bupparenoo, Rattapol Pakchotanon, Pongthorn Narongroeknawin, Paijit Asavatanabodee & Sumapa Chaiamnuay. (2021) Effect of Curcumin on Serum Urate in Asymptomatic Hyperuricemia: A Randomized Placebo-Controlled Trial. Journal of Dietary Supplements 18:3, pages 248-260.
Read now
Read now
Articles from other publishers (100)
Guitao Xu, Lele Wu, Hongxuan Yang, Tianfeng Liu, Ying Tong, Jiliang Wan, Bin Han, Lin Zhou & Xuguang Hu. (2024) Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo. Food and Chemical Toxicology 183, pages 114307.
Crossref
Crossref
Yuchen Qu, Yunli Yu, Jie Pan, Haiyan Li, Cheng Cui & Dongyang Liu. (2023) Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies. Seminars in Arthritis and Rheumatism 63, pages 152279.
Crossref
Crossref
Xiaofen Qi, Kaifang Guan, Chunhong Liu, Haoran Chen, Ying Ma & Rongchun Wang. (2023) Whey protein peptides PEW and LLW synergistically ameliorate hyperuricemia and modulate gut microbiota in potassium oxonate and hypoxanthine-induced hyperuricemic rats. Journal of Dairy Science 106:11, pages 7367-7381.
Crossref
Crossref
Siyue Song, Moqi Fan, Xianghui Wen, Xiaowei Shi, Yu Lou, Zhixing He, Chengping Wen & Tiejuan Shao. (2023) Integrated network pharmacology and gut microbiome analysis to reveal the mechanism of Qu-Zhuo-Tong-Bi decoction against hyperuricemia and gout. Journal of Ethnopharmacology 316, pages 116736.
Crossref
Crossref
Jingna Zheng, Shiting Gong, Gong Wu, Xiaohong Zheng, Jincan Li, Juan Nie, Yanlu Liu, Baoyi Chen, Yuhong Liu, Ziren Su, Jiannan Chen & Yucui Li. (2023) Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells. Naunyn-Schmiedeberg's Archives of Pharmacology 396:10, pages 2405-2416.
Crossref
Crossref
Yan Zhang, Yao Li, Chang Li, Yani Zhao, Lu Xu, Shanbo Ma, Fen Lin, Yanhua Xie, Junming An & Siwang Wang. (2023) Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters. Phytomedicine 118, pages 154957.
Crossref
Crossref
Fengwei Lin, Ming Sun, Jun Gao, Bing Zhang, Qing Mao, Ziyang Bao, Chao Shen, Qiuhua Li, Han Wang & Shaojie Wang. (2023) Identification of 5-[5-cyano-1-(pyridin-2-ylmethyl)-1H-indole-3-carboxamido] thiazole-4-carboxylic acid as a promising dual inhibitor of urate transporter 1 and xanthine oxidase. European Journal of Medicinal Chemistry 257, pages 115532.
Crossref
Crossref
Luxi Cao, Bei Ma, Bingxiang Yi, Yaru Liu & Jiaying Sun. (2023)
Discovery of Natural Multitarget Xanthine Oxidase Inhibitors for Therapeutic Hyperuricemia Using Virtual Screening, Network Pharmacology and
in vitro
Experimental Verification
. ChemistrySelect 8:30.
Crossref
Crossref
Xiaoyu Cao, Jingyuan Cai, Yu Zhang, Chao Liu, Meijie Song, Qianqian Xu, Yang Liu & Hai Yan. (2023) Biodegradation of Uric Acid by Bacillus paramycoides-YC02. Microorganisms 11:8, pages 1989.
Crossref
Crossref
Bingxiang Yi, Jiaying Sun, Yaru Liu, Zhiping Zhang, Rui Wang, Mao Shu & Zhihua Lin. (2023) Virtual Screening and Multi-targets Investigation of Novel Diazine Derivatives
as Potential Xanthine Oxidase Inhibitors Based on QSAR, Molecular
Docking, ADMET Properties, Dynamics Simulation and Network
Pharmacology. Medicinal Chemistry 19:7, pages 704-716.
Crossref
Crossref
Yueyi Zhang, Shan Wang, Xuan Dai, Tianyuan Liu, Yage Liu, Hanfen Shi, Jiyuan Yin, Tianshu Xu, Yanfei Zhang, Dandan Zhao, Vasily Sukhorukov, Alexander N. Orekhov, Sihua Gao, Lili Wang & Dongwei Zhang. (2023) Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice. Journal of Ethnopharmacology 312, pages 116530.
Crossref
Crossref
Alan Kivitz, Wesley DeHaan, Rehan Azeem, Justin Park, Sheri Rhodes, Jamie Inshaw, Sheldon S. Leung, Savvas Nicolaou, Lloyd Johnston, Takashi K. Kishimoto, Peter G. Traber, Earl Sands & Hyon Choi. (2023) Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110). Rheumatology and Therapy 10:4, pages 825-847.
Crossref
Crossref
Armachius James, Ke Wang & Yousheng Wang. (2023) Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates. Nutrients 15:13, pages 3022.
Crossref
Crossref
Xiao-Li Guo, Yan-Yan Gao, Ya-Xin Yang, Qin-Feng Zhu, Huan-Yu Guan, Xun He, Chun-Lei Zhang, Ya Wang, Guo-Bo Xu, Shu-Han Zou, Mao-Chen Wei, Jian Zhang, Jin-Juan Zhang & Shang-Gao Liao. (2023) Amelioration effects of α-viniferin on hyperuricemia and hyperuricemia-induced kidney injury in mice. Phytomedicine 116, pages 154868.
Crossref
Crossref
An Jia, Fei Liu & Si-Yang Fan. (2023) In Vivo Antihyperuricemic Activities of 3,4,5-Tri-O-caffeoylquinic acid, 4,4',6'-Trihydroxy-2'-Methoxychalcone, and Caffeic Acid from the Aerial Parts of Gnaphalium Affine. Pharmaceutical Fronts 05:02, pages e77-e83.
Crossref
Crossref
Priyanka Ghosh, Subhasish Ganguly, Shyamal Kumar Mukherjee, Souvik Dutta, Abdur Rahaman Shaikh, Sk Swaif Ali, Navin Kumar Singh, Pulakendu Bhattacharya, Munmun Koley & Subhranil Saha. (2022) Individualized Homeopathic Medicines in Treatment of Hyperuricemia: Evaluation by Double-Blind, Randomized, Placebo-Controlled Trial. Homeopathy 112:02, pages 085-096.
Crossref
Crossref
Mei Bi, Ao Feng, Yazhuo Liu & Simiao Tian. (2023) U-shaped association of serum uric acid with cardiovascular disease risk scores and the modifying role of sex among Chinese adults. Nutrition, Metabolism and Cardiovascular Diseases 33:5, pages 1066-1076.
Crossref
Crossref
Arrigo F. G. Cicero, Federica Fogacci, Valentina Di Micoli, Cristina Angeloni, Marina Giovannini & Claudio Borghi. (2023) Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential. International Journal of Molecular Sciences 24:8, pages 7027.
Crossref
Crossref
Ahmad Naoras Bitar & Syed Azhar Syed Sulaiman. (2022)
The evidence from clinical trials on Gout medicines effect on
COVID
‐19: A protocol for systematic review and meta‐analysis
. Nursing Open 10:4, pages 2684-2688.
Crossref
Crossref
Zsófia Onódi, Sheryl Koch, Jack Rubinstein, Péter Ferdinandy & Zoltán V. Varga. (2022) Drug repurposing for cardiovascular diseases: New targets and indications for probenecid. British Journal of Pharmacology 180:6, pages 685-700.
Crossref
Crossref
Lifei Fan, Yuqin Guo, Qingmei Wu, Tingting Hu, Xiaomei Chen, Jing Guo, Ying Liu, Yuhui Lu & Min Lin. (2023) Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-18.
Crossref
Crossref
Zhichao Huang, Wugang Zhang, Qiong An, Yifan Lang, Ye Liu, Huifang Fan & Haifang Chen. (2023) Exploration of the anti-hyperuricemia effect of TongFengTangSan (TFTS) by UPLC-Q-TOF/MS-based non-targeted metabonomics. Chinese Medicine 18:1.
Crossref
Crossref
Juan M. Rodríguez, Marco Garranzo, José Segura, Belén Orgaz, Rebeca Arroyo, Claudio Alba, David Beltrán & Leónides Fernández. (2023) A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines. Frontiers in Microbiology 14.
Crossref
Crossref
Chenjing Wang, Qing Yu, Xin Jiang, Yujie Deng, Feifei Sun, Xin Li, Ye Tao, Pingping Lin, Yaping Ma, Yuxian Zhu, Chengqian Li & Yu Cao. (2022) A Drug–Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia. The Journal of Clinical Pharmacology 63:2, pages 239-249.
Crossref
Crossref
Gaoxiang Ai, Ronglei Huang, Jianhui Xie, Linjiang Zhong, Xiaoyan Wu, Zehui Qin, Ziren Su, Jiannan Chen, Xiaobo Yang & Yaoxing Dou. (2023) Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis. Journal of Ethnopharmacology 301, pages 115775.
Crossref
Crossref
Ya-Jia Li, Li-Rong Chen, Zhong-Lei Yang, Ping Wang, Fang-Fang Jiang, Yu Guo, Kai Qian, Mei Yang, Sun-Jun Yin & Gong-Hao He. (2022) Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis. Clinical Rheumatology 42:1, pages 215-224.
Crossref
Crossref
Dewei Xie, Yaling Shen, Erzheng Su, Lei Du, Jingli Xie & Dongzhi Wei. (2022) Anti‐Hyperuricemic, Nephroprotective, and Gut Microbiota Regulative Effects of Separated Hydrolysate of α‐Lactalbumin on Potassium Oxonate‐ and Hypoxanthine‐Induced Hyperuricemic Mice. Molecular Nutrition & Food Research 67:1.
Crossref
Crossref
Olusegun Samson Ajala, Ayotomiwa Olubusayo Ayeleso, Mbang Owolabi, Moshood Olusola Akinleye & Grace Ukpo. (2022) Xanthine oxidase inhibitory potentials of flavonoid aglycones of Tribulus terrestris: in vivo, in silico and in vitro studies. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
Jian Zhang, Yue Dong, Shenghua Gao, Xujie Zhang, Hui Liao, Xiaoyu Shi, Zhijiao Zhang, Tong Zhao, Ruipeng Liang, Danhui Qi, Ting Wu, Jianxin Pang, Xinyong Liu & Peng Zhan. (2022) Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors. European Journal of Medicinal Chemistry 244, pages 114816.
Crossref
Crossref
Yvelise Ferro, Samantha Maurotti, Elisa Mazza, Roberta Pujia, Angela Sciacqua, Vincenzo Musolino, Vincenzo Mollace, Arturo Pujia & Tiziana Montalcini. (2022) Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease. Medicina 58:12, pages 1728.
Crossref
Crossref
Yongmei Li, Lu Li, Jinhong Tian, Fengxin Zheng, Hui Liao, Zean Zhao, Yanyu Chen, Jianxin Pang & Ting Wu. (2022) Insoluble Fiber in Barley Leaf Attenuates Hyperuricemic Nephropathy by Modulating Gut Microbiota and Short-Chain Fatty Acids. Foods 11:21, pages 3482.
Crossref
Crossref
Derya Kaya, Serap Cilaker Micili, Ceren Kizmazoglu, Ali Osman Mucuoglu, Sibel Buyukcoban, Nevin Ersoy, Osman Yilmaz & Ahmet Turan Isik. (2022) Allopurinol attenuates repeated traumatic brain injury in old rats: A preliminary report. Experimental Neurology 357, pages 114196.
Crossref
Crossref
Qianghua Yuan, Yuan Cheng, Rong Sheng, Yan Yuan & Mei Hu. (2022) A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-16.
Crossref
Crossref
Siyao Sang, Lufei Wang, Taotao Liang, Mingjie Su & Hui Li. (2022) Potential role of tea drinking in preventing hyperuricaemia in rats: biochemical and molecular evidence. Chinese Medicine 17:1.
Crossref
Crossref
Suiwen Ye, Wei Zhuang, Yunni Lin, Xiuping Lai, Junyi Chen, Jing Wang, Guoping Zhong, Herui Yao & Junyan Wu. (2022) A Phase I, Randomized, Single-Ascending-Dose, Multiple-Dose, and Food-Effect Trial of the Safety, Efficacy, and Pharmacokinetics of Topiroxostat in Healthy Chinese Participants. BIO Integration 3:3, pages 93-102.
Crossref
Crossref
Yu Wang, Zhi-jian Lin, Jing Huang, Meng-zhen Chu, Xue-li Ding, Wen-jing Li, Qiu-yue Mao & Bing Zhang. (2022) An integrated study of Shenling Baizhu San against hyperuricemia: Efficacy evaluation, core target identification and active component discovery. Journal of Ethnopharmacology 295, pages 115450.
Crossref
Crossref
Christopher Jenkins, Jennifer H. Hwang, Jeffrey B. Kopp, Cheryl A. Winkler & Sung Kweon Cho. (2022) Review of Urate-Lowering Therapeutics: From the Past to the Future. Frontiers in Pharmacology 13.
Crossref
Crossref
Letian Yang, Bo Wang, Liang Ma & Ping Fu. (2022) Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Edward M. Huddleston & Angelo L. Gaffo. (2022) Emerging strategies for treating gout. Current Opinion in Pharmacology 65, pages 102241.
Crossref
Crossref
Christina Kostantini, Sumit Arora, Erik Söderlind, Jens Ceulemans, Christos Reppas & Maria Vertzoni. (2022) Usefulness of Optimized Human Fecal Material in Simulating the Bacterial Degradation of Sulindac and Sulfinpyrazone in the Lower Intestine. Molecular Pharmaceutics 19:7, pages 2542-2548.
Crossref
Crossref
Tatsuya Maruhashi, Yukihito Higashi, Hisako Yoshida, Atsushi Tanaka, Kazuo Eguchi, Hirofumi Tomiyama, Kazuomi Kario, Toru Kato, Nozomu Oda, Nobuhiro Tahara, Mitsutoshi Oguri, Hirotaka Watada & Koichi Node. (2022) Long-Term Effect of Febuxostat on Endothelial Function in Patients With Asymptomatic Hyperuricemia: A Sub-Analysis of the PRIZE Study. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Shih-Wei Lai, Kuan-Fu Liao, Yu-Hung Kuo, Chiu-Shong Liu & Bing-Fang Hwang. (2022) Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia. Journal of Personalized Medicine 12:5, pages 697.
Crossref
Crossref
Jin-Rong Cai, Xin-Wen Chen, Yu-Jian He, Bin Wu, Min Zhang & Li-Hao Wu. (2022) Washed microbiota transplantation reduces serum uric acid levels in patients with hyperuricaemia. World Journal of Clinical Cases 10:11, pages 3401-3413.
Crossref
Crossref
Ralph A. Tripp & David E. Martin. (2022) Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Viruses 14:3, pages 612.
Crossref
Crossref
Yan Hu, Yingfeng Shi, Hui Chen, Min Tao, Xun Zhou, Jinqing Li, Xiaoyan Ma, Yi Wang & Na Liu. (2022) Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis. Frontiers in Immunology 13.
Crossref
Crossref
Yuhui Huang, Shen Zhang, Jiadong Shen, Jiaxi Yang, Xiao Chen, Wanlu Li, Jiawen Wang, Xiaolin Xu, Xin Xu, Zuyun Liu, Xue Li, Yanan Ma & Changzheng Yuan. (2022) Association of plasma uric acid levels with cognitive function among non-hyperuricemia adults: A prospective study. Clinical Nutrition 41:3, pages 645-652.
Crossref
Crossref
Shuiqing He, Qianqian Xiong, Chong Tian, Li Li, Jing Zhao, Xuechun Lin, Xiaolei Guo, Yuqin He, Wangqun Liang, Xuezhi Zuo & Chenjiang Ying. (2021) Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients. European Journal of Nutrition 61:2, pages 665-677.
Crossref
Crossref
Hui Yin, Na Liu & Jie Chen. (2022) The Role of the Intestine in the Development of Hyperuricemia. Frontiers in Immunology 13.
Crossref
Crossref
思琦 郭. (2022) Research Progress of Hyperuricemia and Chronic Renal Failure. Advances in Clinical Medicine 12:04, pages 2923-2927.
Crossref
Crossref
Stefan A. J. Buck, C. Louwrens Braal, Maaike M. Hofman, Esther Oomen-de Hoop, Peter de Bruijn, Inge M. Ghobadi Moghaddam-Helmantel, Koen G. A. M. Hussaarts, Mijntje B. Vastbinder, Quirine C. van Rossum-Schornagel, Ron H. N. van Schaik, Agnes Jager, Stijn L. W. Koolen & Ron H. J. Mathijssen. (2022) Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment. Therapeutic Advances in Medical Oncology 14, pages 175883592210810.
Crossref
Crossref
Ze-an Zhao, Yu Jiang, Yan-yu Chen, Ting Wu, Qun-sheng Lan, Yong-mei Li, Lu Li, Yang Yang, Cui-ting Lin, Ying Cao, Ping-zheng Zhou, Jia-yin Guo, Yuan-xin Tian & Jian-xin Pang. (2021) CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia. Acta Pharmacologica Sinica 43:1, pages 121-132.
Crossref
Crossref
Panchalee Satpanich, Wanjak Pongsittisak & Siriporn Manavathongchai. (2021) Early versus Late Allopurinol Initiation in Acute Gout Flare (ELAG): a randomized controlled trial. Clinical Rheumatology 41:1, pages 213-221.
Crossref
Crossref
Fei Yang, Wenjun Shi, Liting Wang, Nankun Qin, Chengxiang Wang, Yuying Guo, Guang Xu, Jie Fang, Xue Yu & Qun Ma. (2021) Lipidomics study of the therapeutic mechanism of Plantaginis Semen in potassium oxonate-induced hyperuricemia rat. BMC Complementary Medicine and Therapies 21:1.
Crossref
Crossref
Chun-Lei Zhang, Jin-Juan Zhang, Qin-Feng Zhu, Huan-Yu Guan, Ya-Xin Yang, Xun He, Yao Fu, Teng-Xiang Chen, Li Dong, Xiao-Sheng Yang, Kai-Fa Tang, Guo-Bo Xu & Shang-Gao Liao. (2021) Antihyperuricemia and antigouty arthritis effects of Persicaria capitata herba in mice. Phytomedicine 93, pages 153765.
Crossref
Crossref
Yoshifuru Tamura, Chikayuki Morimoto, Emiko Kuribayashi-Okuma, Shunya Uchida, Makoto Hosoyamada, Takahiko Nakagawa & Shigeru Shibata. (2021) Melinjo seed extract stimulates intestinal ABCG2 expression to reduce serum uric acid levels in hyperuricemic rats. Journal of Functional Foods 87, pages 104849.
Crossref
Crossref
Baixi Shan, Ting Chen, Bixia Huang, Yang Liu & Jun Chen. (2021) Untargeted metabolomics reveal the therapeutic effects of Ermiao wan categorized formulas on rats with hyperuricemia. Journal of Ethnopharmacology 281, pages 114545.
Crossref
Crossref
Guoshu Lin, Qiuxia Yu, Lieqiang Xu, Ziwei Huang, Liting Mai, Linyun Jiang, Ziren Su, Jianhui Xie, Yucui Li, Yuhong Liu, Zhixiu Lin & Jiannan Chen. (2021) Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway. European Journal of Pharmacology 912, pages 174592.
Crossref
Crossref
Li Xu, Li Li Lu & Jian Dong Gao. (2021) Traditional Chinese Herbal Medicine Plays a Role in the Liver, Kidney, and Intestine to Ameliorate Hyperuricemia according to Experimental Studies. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-13.
Crossref
Crossref
Ying Chen, Ruya You, Ke Wang & Yousheng Wang. (2021) Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-12.
Crossref
Crossref
Chunsheng Zhu, Bao Sun, Bing Zhang & Zheng Zhou. (2021) An update of genetics, co‐morbidities and management of hyperuricaemia. Clinical and Experimental Pharmacology and Physiology 48:10, pages 1305-1316.
Crossref
Crossref
Shih-Wei Lai, Kuan-Fu Liao, Yu-Hung Kuo, Cheng-Li Lin, Chiu-Shong Liu & Bing-Fang Hwang. (2021) A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia. Frontiers in Pharmacology 12.
Crossref
Crossref
Yoon-Young Sung & Dong-Seon Kim. (2021) Eggshell Membrane Ameliorates Hyperuricemia by Increasing Urate Excretion in Potassium Oxonate-Injected Rats. Nutrients 13:10, pages 3323.
Crossref
Crossref
Jackelyn Murray, Robert J. Hogan, David E. Martin, Kathy Blahunka, Fred D. Sancilio, Rajiv Balyan, Mark Lovern, Richard Still & Ralph A. Tripp. (2021) Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro. Scientific Reports 11:1.
Crossref
Crossref
Fei Liu, Xi-Zi Liu, Qian Yang, Shi-Yi Han & Si-Yang Fan. (2021) Enhanced Efficacy and Reduced Hepatotoxicity by Combination of Gnaphalium affine Extract and Benzbromarone in the Treatment of Rats with Hyperuricemic Nephropathy. Pharmaceutical Fronts 03:03, pages e129-e137.
Crossref
Crossref
Yoon-Young Sung, Heung Joo Yuk & Dong-Seon Kim. (2021) Saengmaeksan, a traditional herbal formulation consisting of Panax ginseng, ameliorates hyperuricemia by inhibiting xanthine oxidase activity and enhancing urate excretion in rats. Journal of Ginseng Research 45:5, pages 565-574.
Crossref
Crossref
Nan Jiang, Chunqin Xu, Linhan Zhang & Jianhua Chen. (2021) “Resurrected” human-source urate oxidase with high uricolytic activity and stability. Enzyme and Microbial Technology 149, pages 109852.
Crossref
Crossref
Subuhi Kaul, Manasvi Gupta, Dhrubajyoti Bandyopadhyay, Adrija Hajra, Prakash Deedwania, Edward Roddy, Mamas Mamas, Allan Klein, Carl J. Lavie, Gregg C. Fonarow & Raktim K. Ghosh. (2020) Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes. American Journal of Cardiovascular Drugs 21:5, pages 499-512.
Crossref
Crossref
Deepa Kumari & Jeffrey L. Brodsky. (2021) The Targeting of Native Proteins to the Endoplasmic Reticulum-Associated Degradation (ERAD) Pathway: An Expanding Repertoire of Regulated Substrates. Biomolecules 11:8, pages 1185.
Crossref
Crossref
Abbasi Muhammad Tanzeel, Asghar Muhammad Rashid, Bashir Khuram & Hashmi Muhammad Nauman. (2021) Hyperuricemia in Renal patients: Treat or not to treat. Archives of Clinical Nephrology, pages 050-056.
Crossref
Crossref
George L. Bakris, Hidetaka Mikami, Masayuki Hirata, Akihiro Nakajima & Michael D. Cressman. (2021) A Non-purine Xanthine Oxidoreductase Inhibitor Reduces Albuminuria in Patients with DKD: A Randomized Controlled Trial. Kidney360 2:8, pages 1240-1250.
Crossref
Crossref
Sheng‐Wen Wu, Chin‐Yin Liu, Chih‐Jung Yeh, Yu‐Hsun Wang & James Cheng‐Chung Wei. (2021) Association of urate‐lowering drugs with the risk of future urolithiasis in patients with gout: A population‐based nested case–control study. International Journal of Clinical Practice 75:8.
Crossref
Crossref
Huilong Xiang, Huan Lei, Ziyuan Liu, Yongjie Liu, Yang Li, Yinsheng Qiu & Lingyun Xu. (2021) Network pharmacology and molecular docking analysis on molecular targets: Mechanisms of baicalin and baicalein against hyperuricemic nephropathy. Toxicology and Applied Pharmacology 424, pages 115594.
Crossref
Crossref
Alexandra Charlton & Paul Anthony MacMullan. (2021) Is Febuxostat Use Associated With Increased Risk of Cardiovascular Disease Events? The Answer Is Crystal Clear. The Journal of Rheumatology 48:7, pages 965-966.
Crossref
Crossref
Hao Deng, Bao Long Zhang, Jin Dong Tong, Xiu Hong Yang & Hui Min Jin. (2021) Febuxostat Use and Risks of Cardiovascular Disease Events, Cardiac Death, and All-cause Mortality: Metaanalysis of Randomized Controlled Trials. The Journal of Rheumatology 48:7, pages 1082-1089.
Crossref
Crossref
Yongmei Li, Zean Zhao, Jian Luo, Yanqing Jiang, Lu Li, Yanyu Chen, Leqi Zhang, Qinghua Huang, Ying Cao, Pingzheng Zhou, Ting Wu & Jianxin Pang. (2021) Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway. Phytomedicine 87, pages 153585.
Crossref
Crossref
Elif Baki Kekilli, Ilkay Erdogan Orhan, F. Sezer Senol Deniz, Gokcen Eren, Esra Emerce, Ahmet Kahraman & I. Ayhan Aysal. (2021) Erodium birandianum Ilarslan & Yurdak. shows anti-gout effect through xanthine oxidase inhibition: Combination of in vitro and in silico techniques and profiling of main components by LC-Q-ToF-MS. Phytochemistry Letters 43, pages 80-87.
Crossref
Crossref
Min-Wei Hsieh, Huey-Yueh Chen & Cheng-Chih Tsai. (2021) Screening and Evaluation of Purine-Nucleoside-Degrading Lactic Acid Bacteria Isolated from Winemaking Byproducts In Vitro and Their Uric Acid-Lowering Effects In Vivo. Fermentation 7:2, pages 74.
Crossref
Crossref
Lieqiang Xu, Guoshu Lin, Qiuxia Yu, Qiaoping Li, Liting Mai, Juanjuan Cheng, Jianhui Xie, Yuhong Liu, Ziren Su & Yucui Li. (2021) Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice. Frontiers in Pharmacology 12.
Crossref
Crossref
Yundi Duan, Nan Jiang, Jing Chen & Jianhua Chen. (2021) Expression, localization and metabolic function of “resurrected” human urate oxidase in human hepatocytes. International Journal of Biological Macromolecules 175, pages 30-39.
Crossref
Crossref
Liqian Chen, Zhengmao Luo, Ming Wang, Jingru Cheng, Fei Li, Hanqi Lu, Qiuxing He, Yanting You, Xinghong Zhou, Hiu Yee Kwan, Xiaoshan Zhao & Lin Zhou. (2021) The Efficacy and Mechanism of Chinese Herbal Medicines in Lowering Serum Uric Acid Levels: A Systematic Review. Frontiers in Pharmacology 11.
Crossref
Crossref
Arrigo F. G. Cicero, Federica Fogacci, Masanari Kuwabara & Claudio Borghi. (2021) Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update. Medicina 57:1, pages 58.
Crossref
Crossref
Adnan Ali Alghamdi, Jameel Sami Althumali, M Meshal Mohammed Almalki, Ahmad Saeed Almasoudi, Ali Hussain Almuntashiri, Abdulaziz Hassan Almuntashiri, Alkhrizi Ibrahim Mohammed, Ashraf Ali Alkinani, Meshari Saeed Almahdawi & M Ali Hussain Mahzari. (2021) An Overview on the Role of Xanthine Oxidase Inhibitors in Gout Management. Archives Of Pharmacy Practice 12:3, pages 94-99.
Crossref
Crossref
Ilkay E. Orhan & Fatma S.S. Deniz. (2021) Natural Products and Extracts as Xantine Oxidase Inhibitors - A Hope for Gout Disease?. Current Pharmaceutical Design 27:2, pages 143-158.
Crossref
Crossref
Arrigo F.G. Cicero, Federica Fogacci, Raffaele Ivan Cincione, Giuliano Tocci & Claudio Borghi. (2021) Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients. Medical Principles and Practice 30:2, pages 122-130.
Crossref
Crossref
Yi-Jen Fang, Tien-Yuan Wu, Cheng-Li Lin, Chih-Yang Su, Jia-Rong Li, Yun-Lung Chung, Ni Tien & Yun-Ping Lim. (2020) Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on In Vitro Hepatic Lipogenesis-Related Gene Expression. Mediators of Inflammation 2020, pages 1-13.
Crossref
Crossref
Nadine Mbuyi & Catherine Hood. (2020) An update on gout diagnosis and management for the primary care provider. The Nurse Practitioner 45:10, pages 16-25.
Crossref
Crossref
Arrigo Francesco Giuseppe Cicero, Federica Fogacci & Claudio Borghi. (2020) Uric acid and thrombotic risk: an emerging link. Internal and Emergency Medicine 15:7, pages 1167-1168.
Crossref
Crossref
Ellen Y. Cotrina, Ângela Oliveira, José Pedro Leite, Jordi Llop, Luis Gales, Jordi Quintana, Isabel Cardoso & Gemma Arsequell. (2020) Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer. International Journal of Molecular Sciences 21:19, pages 7166.
Crossref
Crossref
Charles F. SchulerIVIV, Carrie‐Anne Malinczak, Shannon K. K. Best, Susan B. Morris, Andrew J. Rasky, Catherine Ptaschinski, Nicholas W. Lukacs & Wendy Fonseca. (2020) Inhibition of uric acid or IL‐1β ameliorates respiratory syncytial virus immunopathology and development of asthma. Allergy 75:9, pages 2279-2293.
Crossref
Crossref
Harmandeep Kaur Gulati, Kavita Bhagat, Atamjit Singh, Nitish Kumar, Arshmeet Kaur, Akriti Sharma, Shilpa Heer, Harbinder Singh, Jatinder Vir Singh & Preet Mohinder S. Bedi. (2020) Design, synthesis and biological evaluation of novel indolinedione–coumarin hybrids as xanthine oxidase inhibitors. Medicinal Chemistry Research 29:9, pages 1632-1642.
Crossref
Crossref
Mingjun Liu, Wenwen Li, Ying Chen, Xianyao Wan & Jia Wang. (2020) Fucoxanthin: A promising compound for human inflammation-related diseases. Life Sciences 255, pages 117850.
Crossref
Crossref
Ying Yang, Lei Zhang, Jinying Tian, Fei Ye & Zhiyan Xiao. (2020) Identification of xanthine oxidase inhibitors through hierarchical virtual screening. RSC Advances 10:46, pages 27752-27763.
Crossref
Crossref
Bin Han, Mengjuan Gong, Zhong Li, Yuqin Qiu & Zhongjie Zou. (2020) NMR-Based Metabonomic Study Reveals Intervention Effects of Polydatin on Potassium Oxonate-Induced Hyperuricemia in Rats. Oxidative Medicine and Cellular Longevity 2020, pages 1-10.
Crossref
Crossref
Wendy Fonseca, Carrie-Anne Malinczak, Charles F. Schuler, Shannon K.K. Best, Andrew J. Rasky, Susan B. Morris, Tracy X. Cui, Antonia P. Popova & Nicholas W. Lukacs. (2020) Uric acid pathway activation during respiratory virus infection promotes Th2 immune response via innate cytokine production and ILC2 accumulation. Mucosal Immunology 13:4, pages 691-701.
Crossref
Crossref
Theodoros Eleftheriadis, Georgios Pissas, Georgia Antoniadi, Georgios Filippidis, Vassilios Liakopoulos & Ioannis Stefanidis. (2020) Urate crystals trigger B-cell receptor signal transduction and induce B-cell proliferation. Journal of Basic and Clinical Physiology and Pharmacology 31:4.
Crossref
Crossref
Antonio Brucato, Francesco Cianci & Carla Carnovale. (2020) Management of hyperuricemia in asymptomatic patients: A critical appraisal. European Journal of Internal Medicine 74, pages 8-17.
Crossref
Crossref
Heting Wang, Hua Duan, Shiyin Chen, Yong Luo, Yuan Zhang, Qingsong Liu & Xiyu Zhang. (2020) Chinese herbal medicine si-miao-san decoction for acute gouty arthritis. Medicine 99:32, pages e21510.
Crossref
Crossref
Ting-Ting Chang & Jaw-Wen Chen. (2020) Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency. Pharmacological Research 151, pages 104509.
Crossref
Crossref
Yukuang Guo, Hyunwoo Lee & Hyunyoung Jeong. 2020. The Microbiome in Health and Disease. The Microbiome in Health and Disease
61
93
.
Ruixia Bao, Mengyang Liu, Dan Wang, Shaoshi Wen, Haiyang Yu, Yi Zhong, Zheng Li, Yi Zhang & Tao Wang. (2019) Effect of Eurycoma longifolia Stem Extract on Uric Acid Excretion in Hyperuricemia Mice. Frontiers in Pharmacology 10.
Crossref
Crossref